Michael Finney Overview

  • Investor Type
  • Angel

  • Investments
  • 2

  • Portfolio
  • 1

  • Exits
  • 1

Exits

Michael Finney General Information

Description

Dr. Michael Finney serves as Managing Director of Finney Capital. He serves as a Member at Life Science Angels. He co-founded and served as Chairman at Addition Therapeutics. He serves as Chairman at Thrive Bioscience. He also serves as the Board Member of Orion Genomics. He has been Acting as Chief Executive Officer of Vaxart Inc. since July 2009. Dr. Finney serves as Chief Scientific Officer of MJ Bioworks Inc. Dr. Finney Co-founded MJ Research, Incorporated in 1987. He founded MJ Bioworks. He has experience with founding and managing start-up companies. He served as Chief Scientific Officer of MJ Research Inc. He served as an Advisor of Vaxart Inc. He serves as Chairman & Advisor at Sage Science. He serves as Director of Vaxart, Inc. He serves as Director of Orion Genomics LLC. He serves as a Director of WaveMark Inc. He served as a Director of PharmaSecure, Inc. He served as a Scientific Advisor of Orion Genomics LLC. Dr. Finney is the author of numerous scientific articles and holds 7 US patents. Dr. Finney completed postdoctoral work at the Harvard Medical School Department of Genetics at Massachusetts General Hospital from 1987 to 1990. Dr. Finney received a BA in Biochemical Sciences from Harvard University in 1980 and a Ph.D. in Biology from the Massachusetts Institute of Technology in 1987. He was a founder and Chief Scientific Officer of MJ Research and is currently an investor in over a dozen privately-held companies in biotechnology, alternative energy, and allied areas. He is a director of the privately-held companies Vaxart, Wavemark, Innerscope Research, Sage Science and Board Member at Banyan Energy, a director of the non-profit G Corp (administrator of the industry-leading AGBT Genomics meeting), and a past director of Mission Motors and Pharmasecure; he is also former Chief Executive Officer of Vaxart. Dr. Finney was a Postdoctoral Fellow at Harvard Medical School/Massachusetts General Hospital. He holds eight U.S. patents.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • 170 Harbor Way
  • Suite 300
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Michael Finney Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Intabio 14-Sep-2017 Seed Round 00.00 Discovery Tools (Healthcare) Generating Revenue 0000000 000000 00.0
Thrive Bioscience 30-Apr-2015 0000 00000 000 Other Healthcare Technology Systems Generating Revenue 0000000 000000 00.0

Michael Finney Exits (1)

Company Name Exit Date Exit Type Exit Size
Intabio 21-Jan-2021 000000000000000000

Michael Finney Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Michael Finney Team (1)

Name Title Deals Funds Boards Office
Michael Finney Ph.D Angel Investor 00 0 South San Francisco, CA

Michael Finney FAQs

  • Who is Michael Finney?

    Michael Finney is an angel Investor who has made 2 investments.

  • What kind of investor is Michael Finney?

    Michael Finney is an angel investor.

  • What does Michael Finney do?

    As an angel investor, Michael Finney invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Michael Finney hold?

    Michael Finney holds 2 board seats including Orion Genomics and Banyan Energy.

  • What has Michael Finney invested in?

    Michael Finney has made numerous investments in companies like Intabio and Thrive Bioscience within the Discovery Tools (Healthcare) and Healthcare Technology Systems industries.

  • What has Michael Finney invested in recently?

    Michael Finney's latest investment was on 14-Sep-2017 in Intabio, a company within the Discovery Tools (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »